ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ATHA Athira Pharma Inc

2.04
0.00 (0.00%)
Pre Market
Last Updated: 03:13:19
Delayed by 15 minutes

Period:

Draw Mode:

Volume 100
Bid Price 2.04
Ask Price 2.43
News -
Day High

Low
1.33

52 Week Range

High
4.2984

Day Low
Share Name Share Symbol Market Stock Type
Athira Pharma Inc ATHA NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 2.04 03:13:19
Open Price Low Price High Price Close Price Previous Close
2.04
Trades Shares Traded Average Volume 52 Week Range
2 100 - 1.33 - 4.2984
Last Trade Type Quantity Price Currency
03:13:19 34 US$ 2.04 USD

Athira Pharma Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
78.19M 38.33M - 1.63M -117.67M -3.07 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Athira Pharma News

Date Time Source News Article
4/15/202406:00GlobeNewswire Inc.Athira Pharma Appoints Javier San Martin, M.D., as Chief..
4/11/202406:00GlobeNewswire Inc.Athira Pharma Announces Publication of Preclinical Data..
4/03/202406:00GlobeNewswire Inc.Athira Pharma Announces Upcoming Poster Presentation at..
3/08/202406:00GlobeNewswire Inc.Athira Pharma Presents Clinical and Preclinical Data..
2/22/202415:34Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee..
2/22/202415:10Edgar (US Regulatory)Form 8-K - Current report
2/22/202415:05GlobeNewswire Inc.Athira Pharma Reports Full Year 2023 Financial Results and..
2/16/202416:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/16/202415:54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/16/202415:46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/16/202415:40Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of..
2/08/202415:02GlobeNewswire Inc.Athira Pharma Announces Publication in Frontiers in..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No ATHA Message Board. Create One! See More Posts on ATHA Message Board See More Message Board Posts

Historical ATHA Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week2.162.262.0212.09145,373-0.12-5.56%
1 Month2.582.8252.0212.41218,883-0.54-20.93%
3 Months3.094.29842.0213.04367,605-1.05-33.98%
6 Months1.614.29841.332.68346,3190.4326.71%
1 Year2.794.29841.332.71272,311-0.75-26.88%
3 Years18.0723.63991.337.13434,389-16.03-88.71%
5 Years19.9534.791.339.16418,494-17.91-89.77%

Athira Pharma Description

Athira Pharma Inc is a biotechnology company focused on developing small molecules to restore neuronal health and stop neurodegeneration. The company is developing treatments for Alzheimer's disease and Parkinson's disease.

Your Recent History

Delayed Upgrade Clock